{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:15:58Z","timestamp":1794492958368,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>We are committed to demonstrating that the initial triglyceride-glucose (TyG) index possesses prognostic importance for patients undergoing continuous ambulatory peritoneal dialysis (CAPD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>354 patients who utilized continuous CAPD at Wuhan No.1 Hospital were recruited. The participants were classified into three unique groups according to the tertiles of the TyG index. The main endpoints were overall and cardiovascular (CVD) mortality, whereas the secondary outcomes were peritonitis, technical failure, and early-onset peritonitis. The association between the TyG index and outcomes utilizing Cox proportional hazard and restricted cubic spline analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Over a median follow-up of 72 months, 92 patients (26.0%) and 60 patients (16.9%) succumbed to all-cause and CVD mortality, respectively. The three groups exhibited significant differences for all-cause death (16.8% in tertile 1, 24.8% in tertile 2, and 36.4% in tertile 3). After full adjustment, patients with the highest TyG index demonstrated a significantly increased all-cause death relative to those in the lowest tertile (hazard ratio, HR, 2.31, 95% confidence interval, 95%CI 1.18\u20134.56, <jats:italic>P<\/jats:italic>\u2009=\u20090.015). Similarly, each unit increase in the TyG index was associated with a 1.32-fold elevated risk of all-cause death (HR 1.32, 95% CI 1.06\u20131.87, <jats:italic>P<\/jats:italic>\u2009=\u20090.031). Restricted cubic spline analysis indicated a relationship between the TyG index and all-cause mortality (P for nonlinearity\u2009&gt;\u20090.05). Furthermore, the same findings were also seen with CVD mortality and secondary outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The TyG index may function as a meaningful and reliable prognostic indicator in CAPD patients, suggesting its potential importance in improving risk stratification in clinical environments.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04305-x","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T01:57:40Z","timestamp":1751853460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic value of the triglyceride-glucose index for continuous ambulatory peritoneal dialysis patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Sheng","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanglin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengsi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"4305_CR1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41581-022-00623-7","volume":"18","author":"AK Bello","year":"2022","unstructured":"Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol. 2022;18:779\u201393.","journal-title":"NAT REV NEPHROL"},{"key":"4305_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/j.ajkd.2022.07.004","volume":"81","author":"BL Auguste","year":"2023","unstructured":"Auguste BL, Bargman JM. Peritoneal Dialysis prescription and adequacy in clinical practice: core curriculum 2023. Am J Kidney Dis. 2023;81:100\u20139.","journal-title":"AM J KIDNEY DIS"},{"key":"4305_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41581-020-0315-4","volume":"16","author":"J Himmelfarb","year":"2020","unstructured":"Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M. The current and future landscape of dialysis. Nat Rev Nephrol. 2020;16:573\u201385.","journal-title":"NAT REV NEPHROL"},{"key":"4305_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.semnephrol.2018.02.007","volume":"38","author":"D Jegatheesan","year":"2018","unstructured":"Jegatheesan D, Cho Y, Johnson DW. Clinical studies of interventions to mitigate cardiovascular risk in peritoneal Dialysis patients. Semin Nephrol. 2018;38:277\u201390.","journal-title":"SEMIN NEPHROL"},{"key":"4305_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.endonu.2014.06.009","volume":"61","author":"G Unger","year":"2014","unstructured":"Unger G, Benozzi SF, Perruzza F, Pennacchiotti GL. Triglycerides and glucose index: a useful indicator of insulin resistance. Endocrinol Nutr. 2014;61:533\u201340.","journal-title":"ENDOCRINOL NUTR"},{"key":"4305_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.31083\/j.rcm.2020.01.5102","volume":"21","author":"MM Adeva-Andany","year":"2020","unstructured":"Adeva-Andany MM, Fernandez-Fernandez C, Carneiro-Freire N, Castro-Quintela E, Pedre-Pineiro A, Seco-Filgueira M. Insulin resistance underlies the elevated cardiovascular risk associated with kidney disease and glomerular hyperfiltration. Rev Cardiovasc Med. 2020;21:41\u201356.","journal-title":"REV CARDIOVASC MED"},{"key":"4305_CR7","doi-asserted-by":"publisher","first-page":"655741820","DOI":"10.1177\/03000605231164548","volume":"51","author":"CE Kosmas","year":"2023","unstructured":"Kosmas CE, Bousvarou MD, Kostara CE, Papakonstantinou EJ, Salamou E, Guzman E. Insulin resistance and cardiovascular disease. J Int Med Res. 2023;51:655741820.","journal-title":"J INT MED RES"},{"key":"4305_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-023-01971-9","volume":"22","author":"Z Yang","year":"2023","unstructured":"Yang Z, Gong H, Kan F, Ji N. Association between the triglyceride glucose (TyG) index and the risk of acute kidney injury in critically ill patients with heart failure: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22:232.","journal-title":"CARDIOVASC DIABETOL"},{"key":"4305_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12933-023-01843-2","volume":"22","author":"Z Ye","year":"2023","unstructured":"Ye Z, An S, Gao Y, et al. Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit. Cardiovasc Diabetol. 2023;22:110.","journal-title":"CARDIOVASC DIABETOL"},{"key":"4305_CR10","doi-asserted-by":"publisher","first-page":"2267127","DOI":"10.1080\/0886022X.2023.2267127","volume":"45","author":"G Liu","year":"2023","unstructured":"Liu G, Yan Q, Wang R, Li D, Cong J, Chen X. Elevated triglyceride-glucose index predisposes to the initial episode of peritonitis in chronic peritoneal dialysis patients. Ren Fail. 2023;45:2267127.","journal-title":"Ren Fail"},{"key":"4305_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12882-024-03493-2","volume":"25","author":"S Wan","year":"2024","unstructured":"Wan S, Hu Y, Cheng L, He D, Wang Z, Zhang Y. Prognostic value of transthoracic echocardiography score for the prognosis of continuous ambulatory peritoneal dialysis patients. Bmc Nephrol. 2024;25:65.","journal-title":"BMC NEPHROL"},{"key":"4305_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12882-018-1092-1","volume":"19","author":"L Cai","year":"2018","unstructured":"Cai L, Yu J, Yu J, et al. Prognostic value of inflammation-based prognostic scores on outcome in patients undergoing continuous ambulatory peritoneal dialysis. Bmc Nephrol. 2018;19:297.","journal-title":"BMC NEPHROL"},{"key":"4305_CR13","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/ndt\/gfh741","volume":"20","author":"D Duman","year":"2005","unstructured":"Duman D, Tokay S, Toprak A, et al. Elevated cardiac troponin T is associated with increased left ventricular mass index and predicts mortality in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transpl. 2005;20:962\u20137.","journal-title":"Nephrol Dial Transpl"},{"key":"4305_CR14","doi-asserted-by":"publisher","first-page":"917603","DOI":"10.3389\/fmed.2022.917603","volume":"9","author":"P Song","year":"2022","unstructured":"Song P, Yang D, Li J, et al. Dynamic serum albumin and outcome of peritoneal dialysis patients: A retrospective study in China. Front Med (Lausanne). 2022;9:917603.","journal-title":"Front Med (Lausanne)"},{"key":"4305_CR15","doi-asserted-by":"publisher","first-page":"2238830","DOI":"10.1080\/0886022X.2023.2238830","volume":"45","author":"Z Jin","year":"2023","unstructured":"Jin Z, Zhang K. Association between triglyceride-glucose index and AKI in ICU patients based on MIMICIV database: a cross-sectional study. Ren Fail. 2023;45:2238830.","journal-title":"Ren Fail"},{"key":"4305_CR16","doi-asserted-by":"publisher","first-page":"e212612","DOI":"10.1001\/jamanetworkopen.2021.2612","volume":"4","author":"J Fritz","year":"2021","unstructured":"Fritz J, Brozek W, Concin H, et al. The Triglyceride-Glucose index and Obesity-Related risk of End-Stage kidney disease in Austrian adults. JAMA Netw Open. 2021;4:e212612.","journal-title":"JAMA Netw Open"},{"key":"4305_CR17","doi-asserted-by":"publisher","first-page":"1342408","DOI":"10.3389\/fendo.2024.1342408","volume":"15","author":"C Yu","year":"2024","unstructured":"Yu C, Shi Y, Wang T, et al. Triglyceride-glucose index change and chronic kidney disease progression in a Chinese hypertensive population. Front Endocrinol (Lausanne). 2024;15:1342408.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4305_CR18","doi-asserted-by":"publisher","first-page":"1150980","DOI":"10.3389\/fendo.2023.1150980","volume":"14","author":"YM Gao","year":"2023","unstructured":"Gao YM, Chen WJ, Deng ZL, Shang Z, Wang Y. Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease. Front Endocrinol (Lausanne). 2023;14:1150980.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4305_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/00015385.2023.2257983","volume":"79","author":"D Karabulut","year":"2024","unstructured":"Karabulut D, Karabulut U, Kalyoncuoglu M, Katkat F, Berber I. Predictive value of triglyceride\/glucose index for cardiac outcomes in non-diabetic renal transplant recipients. ACTA Cardiol. 2024;79:319\u201326.","journal-title":"ACTA CARDIOL"},{"key":"4305_CR20","first-page":"3615","volume":"28","author":"M Engin","year":"2024","unstructured":"Engin M, As AK. Triglyceride glucose index as a marker of primary patency rate of arteriovenous fistula in diabetic Hemodialysis patients. Eur Rev Med Pharmacol Sci. 2024;28:3615\u201320.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4305_CR21","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1002\/jcp.27603","volume":"234","author":"H Yaribeygi","year":"2019","unstructured":"Yaribeygi H, Farrokhi FR, Butler AE, Sahebkar A. Insulin resistance: review of the underlying molecular mechanisms. J Cell Physiol. 2019;234:8152\u201361.","journal-title":"J CELL PHYSIOL"},{"key":"4305_CR22","doi-asserted-by":"publisher","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.","journal-title":"METABOLISM"},{"key":"4305_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21:68.","journal-title":"CARDIOVASC DIABETOL"},{"key":"4305_CR24","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s11255-012-0334-6","volume":"45","author":"G Boudouris","year":"2013","unstructured":"Boudouris G, Verginadis II, Simos YV, et al. Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and E supplementation. Int Urol Nephrol. 2013;45:1137\u201344.","journal-title":"INT UROL NEPHROL"},{"key":"4305_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/0971-4065.75218","volume":"21","author":"Z Hambali","year":"2011","unstructured":"Hambali Z, Ahmad Z, Arab S, Khazaai H. Oxidative stress and its association with cardiovascular disease in chronic renal failure patients. Indian J Nephrol. 2011;21:21\u20135.","journal-title":"Indian J Nephrol"},{"key":"4305_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1744-9987.2011.01009.x","volume":"16","author":"DMA Marques","year":"2012","unstructured":"Marques DMA, Marino LV, Ovidio PP, Jordao AA, Almeida CC, Chiarello PG. Protein oxidative stress and dyslipidemia in dialysis patients. Ther Apher Dial. 2012;16:68\u201374.","journal-title":"THER APHER DIAL"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04305-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04305-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04305-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T01:57:41Z","timestamp":1751853461000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04305-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4305"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04305-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures will be performed in adherence to the Helsinki declaration. This study was approved by the Ethics Committee of Wuhan No. 1 Hospital without the need for informed consent from the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"Patients and\/or the public were not involved in the design, conduct, reporting, or dissemination plans of this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}},{"value":"Not commissioned; externally peer-reviewed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Provenance and peer review"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}